[1] |
Wang LY, Wu WP. Natural factors of alveolar echinococcosis[J]. Chin J Zoonoses, 2009, 25(1):63-66. (in Chinese)
|
|
(王立英, 伍卫平. 泡球蚴病流行的自然因素[J]. 中国人兽共患病学报, 2009, 25(1):63-66.)
|
[2] |
Eckert J, Gemmell MA, Meslin FX, et al. WHO/OIE manual on echinococcosis in human and animals: a public health problem of global concern[M]. Paris: World Organization for Animal Health, 2001: 1-17.
|
[3] |
Holmes P. Investing to overcome the global impact of neglected tropical diseases[R]. Geneva: WHO, 2015, 7(4244):596-596.
|
[4] |
Food and Agriculture Organization of the United Nations/World Health Organization. Multicriteria-based ranking for risk management of food borne parasites[R]. Rome: FAO Headquarters, 2012.
|
[5] |
Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern[J]. Clin Microbiol Rev, 2004, 17(1):107-135.
doi: 10.1128/CMR.17.1.107-135.2004
|
[6] |
Ammann RW, Eckert J. Cestodes. Echinococcus[J]. Gastroenterol Clin North Am, 1996, 25(3):655-689.
doi: 10.1016/S0889-8553(05)70268-5
|
[7] |
WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans[J]. Bull World Health Organ, 1996, 74(3):231-242.
|
[8] |
Kern P, Menezes da Silva A, Akhan O, et al. The echinococcoses: diagnosis, clinical management and burden of disease[J]. Adv Parasitol, 2017, 96:259-369.
|
[9] |
Jura H, Bader A, Frosch M. In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes[J]. Antimicrob Agents Chemother, 1998, 42(5):1052-1056.
pmid: 9593125
|
[10] |
Reuter S, Jensen B, Buttenschoen K, et al. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature[J]. J Antimicrob Chemother, 2000, 46(3):451-456.
doi: 10.1093/jac/46.3.451
|
[11] |
Reuter S, Buck A, Manfras B, et al. Structured treatment interruption in patients with alveolar echinococcosis[J]. Hepatology, 2004, 39(2):509-517.
doi: 10.1002/(ISSN)1527-3350
|
[12] |
Zhu WJ, Han XM, Guo YM. Progress in researches of benzimidazole in treatment of echinococcosis[J]. Chin J Schisto Control, 2017, 29(4):530-533. (in Chinese)
|
|
(朱文君, 韩秀敏, 郭亚民. 苯并咪唑类药物治疗包虫病研究进展[J]. 中国血吸虫病防治杂志, 2017, 29(4):530-533.)
|
[13] |
Liu C, Yin J, Xue J, et al. In vitro effects of amino alcohols on Echinococcus granulosus[J]. Acta Trop, 2018, 182:285-290.
doi: 10.1016/j.actatropica.2017.08.031
|
[14] |
Brehm K, Kronthaler K, Jura H, et al. Cloning and characterization of beta-tubulin genes from Echinococcus multilocularis[J]. Mol Biochem Parasitol, 2000, 107(2):297-302.
doi: 10.1016/S0166-6851(00)00178-X
|
[15] |
Pierce RJ, Dubois-Abdesselem F, Lancelot J, et al. Targeting schistosome histone modifying enzymes for drug development[J]. Curr Pharm Des, 2012, 18(24):3567-3578.
|
[16] |
Parker AL, Teo WS, McCarroll JA, et al. An emerging role for tubulin isotypes in modulating cancer biology and chemotherapy resistance[J]. Int J Mol Sci, 2017, 18(7):1434.
doi: 10.3390/ijms18071434
|
[17] |
Nogales E. Structural insight into microtubule function[J]. Annu Rev Biophys Biomol Struct, 2001, 30:397-420.
doi: 10.1146/annurev.biophys.30.1.397
|
[18] |
Subramanian R, Kapoor TM. Building complexity: insights into self-organized assembly of microtubule-based architectures[J]. Dev Cell, 2012, 23(5):874-885.
doi: 10.1016/j.devcel.2012.10.011
pmid: 23153484
|
[19] |
Mao J, Wang D, Wang Z, et al. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway[J]. Cancer Lett, 2016, 380(1):134-143.
doi: 10.1016/j.canlet.2016.06.020
|
[20] |
Liu M, Zhu YQ, Huang JF, et al. Ubiquitin-conjugating enzyme E2C regulates the progression of hepatocellular carcinoma by specifically binding to β-tubulin[J]. Acad J Second Mil Med Univ, 2021, 42(1):14-20. (in Chinese)
|
|
(刘梦, 朱怡卿, 黄金凤, 等. 泛素结合酶E2C通过特异性结合β-微管蛋白参与调控肝细胞癌进展[J]. 第二军医大学学报, 2021, 42(1):14-20.)
|
[21] |
Froidevaux-Klipfel L, Poirier F, Boursier C, et al. Modulation of septin and molecular motor recruitment in the microtubule environment of the taxol-resistant human breast cancer cell line MDA-MB-231[J]. Proteomics, 2011, 11(19):3877-3886.
doi: 10.1002/pmic.201000789
pmid: 21761557
|
[22] |
Kavallaris M, Kuo DY, Burkhart CA, et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes[J]. J Clin Invest, 1997, 100(5):1282-1293.
pmid: 9276747
|
[23] |
Banerjee A. Increased levels of tyrosinated alpha-, beta(Ⅲ)-, and beta(Ⅳ)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells[J]. Biochem Biophys Res Commun, 2002, 293(1):598-601.
doi: 10.1016/S0006-291X(02)00269-3
|
[24] |
Tamura D, Arao T, Nagai T, et al. Slug increases sensitivity to tubulin-binding agents via the downregulation of βⅢ and βⅣα-tubulin in lung cancer cells[J]. Cancer Med, 2013, 2(2):144-154.
doi: 10.1002/cam4.2013.2.issue-2
|
[25] |
Kusel JR, McVeigh P, Thornhill JA. The schistosome excretory system: a key to regulation of metabolism, drug excretion and host interaction[J]. Trends Parasitol, 2009, 25(8):353-358.
doi: 10.1016/j.pt.2009.05.003
pmid: 19617001
|
[26] |
Bahia D, Avelar LG, Vigorosi F, et al. The distribution of motor proteins in the muscles and flame cells of the Schistosoma mansoni miracidium and primary sporocyst[J]. Parasitology, 2006, 133(Pt 3):321-329.
pmid: 16740180
|
[27] |
Valverde-Islas LE, Arrangoiz E, Vega E, et al. Visualization and 3D reconstruction of flame cells of Taenia solium (Cestoda)[J]. PLoS One, 2011, 6(3):e14754.
doi: 10.1371/journal.pone.0014754
|
[28] |
Rohde K, Watson NA, Roubal FR. Ultrastructure of the protonephridial system of Anoplodiscus cirrusspiralis (Monogenea Monopisthocotylea)[J]. Int J Parasitol, 1992, 22(4):443-457.
pmid: 1644519
|